Kathleen Whalen, the health system’s senior vice president and chief ethics and compliance officer, recently sold $787,000 worth of shares. Many of the company’s officers sold shares in April, including Erol Akdamar, president of the American Group; P. Martin Paslick, chief information officer; and Michael Cuffe, MD, chief clinical officer.
Dr. Cuffe made the largest sale of the year, totaling $3.6 million.
HCA insiders currently own 1.4 percent of the company, yet the recent sales “do not inspire confidence,” the Clayton County Register reported. Stock analyst Simply Wall St. also questioned the company’s strength after seeing C-suite leaders sell.
However, shares of HCA Healthcare have gained 24.4 percent in the past year — 6.1 percent above the industry’s growth. For the first six months of 2023, the company reported revenues of $31.45 billion and net income of $2.56 billion, an improvement from the same time period in 2022.
Becker’s has reached out to HCA and will update this story if more information becomes available.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
